Concepts (235)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electronic Health Records | 5 | 2019 | 121 | 0.920 |
Why?
|
| Diabetes Mellitus, Type 2 | 11 | 2018 | 1389 | 0.860 |
Why?
|
| Hypoglycemic Agents | 8 | 2017 | 177 | 0.790 |
Why?
|
| Risk Assessment | 6 | 2019 | 1328 | 0.690 |
Why?
|
| Psoas Muscles | 1 | 2019 | 19 | 0.680 |
Why?
|
| Sarcopenia | 1 | 2019 | 53 | 0.650 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2019 | 872 | 0.580 |
Why?
|
| Aged | 28 | 2019 | 9572 | 0.570 |
Why?
|
| Models, Statistical | 3 | 2014 | 164 | 0.490 |
Why?
|
| Proportional Hazards Models | 10 | 2019 | 711 | 0.480 |
Why?
|
| Male | 35 | 2019 | 17970 | 0.480 |
Why?
|
| Online Systems | 1 | 2014 | 13 | 0.470 |
Why?
|
| Forecasting | 1 | 2014 | 133 | 0.460 |
Why?
|
| Humans | 43 | 2019 | 29453 | 0.450 |
Why?
|
| Female | 32 | 2019 | 18342 | 0.440 |
Why?
|
| Patient Readmission | 3 | 2019 | 106 | 0.440 |
Why?
|
| Diabetic Angiopathies | 3 | 2017 | 137 | 0.440 |
Why?
|
| Middle Aged | 27 | 2019 | 10920 | 0.440 |
Why?
|
| Cardiovascular Diseases | 3 | 2005 | 1057 | 0.440 |
Why?
|
| United States | 14 | 2019 | 3685 | 0.430 |
Why?
|
| Colorectal Neoplasms | 1 | 2014 | 208 | 0.400 |
Why?
|
| Cohort Studies | 8 | 2019 | 1701 | 0.390 |
Why?
|
| Neoplasms | 5 | 2013 | 621 | 0.380 |
Why?
|
| Point-of-Care Systems | 2 | 2017 | 33 | 0.380 |
Why?
|
| Risk Factors | 17 | 2019 | 3598 | 0.360 |
Why?
|
| Adult | 18 | 2019 | 8513 | 0.350 |
Why?
|
| Cholesterol | 3 | 2005 | 239 | 0.350 |
Why?
|
| C-Reactive Protein | 3 | 2005 | 235 | 0.350 |
Why?
|
| Health Care Costs | 1 | 2009 | 108 | 0.320 |
Why?
|
| Metformin | 4 | 2016 | 19 | 0.320 |
Why?
|
| Iron | 2 | 2005 | 113 | 0.310 |
Why?
|
| Medicare | 2 | 2019 | 189 | 0.310 |
Why?
|
| Delivery of Health Care | 1 | 2009 | 143 | 0.310 |
Why?
|
| Transferrin | 2 | 2005 | 32 | 0.310 |
Why?
|
| Diabetes Mellitus | 2 | 2017 | 376 | 0.300 |
Why?
|
| Chest Pain | 2 | 2019 | 180 | 0.290 |
Why?
|
| Cholesterol, LDL | 2 | 2004 | 164 | 0.280 |
Why?
|
| Medical Records | 2 | 2003 | 68 | 0.270 |
Why?
|
| Patient Discharge | 3 | 2019 | 170 | 0.270 |
Why?
|
| Mortality | 2 | 2017 | 114 | 0.260 |
Why?
|
| Hypothyroidism | 1 | 2005 | 12 | 0.260 |
Why?
|
| Arginine | 1 | 2005 | 18 | 0.260 |
Why?
|
| Autoantibodies | 1 | 2005 | 42 | 0.250 |
Why?
|
| Chlamydophila Infections | 1 | 2004 | 2 | 0.250 |
Why?
|
| Chlamydophila pneumoniae | 1 | 2004 | 4 | 0.250 |
Why?
|
| Macrolides | 1 | 2004 | 8 | 0.250 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2005 | 41 | 0.250 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 796 | 0.240 |
Why?
|
| Myocardial Ischemia | 1 | 2004 | 85 | 0.240 |
Why?
|
| Dementia | 2 | 2005 | 237 | 0.230 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2003 | 21 | 0.230 |
Why?
|
| Nomograms | 3 | 2014 | 30 | 0.230 |
Why?
|
| Resuscitation Orders | 1 | 2003 | 11 | 0.230 |
Why?
|
| Drug Combinations | 1 | 2003 | 86 | 0.230 |
Why?
|
| Religion and Medicine | 1 | 2003 | 19 | 0.220 |
Why?
|
| Unnecessary Procedures | 1 | 2002 | 9 | 0.220 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2002 | 12 | 0.220 |
Why?
|
| Odds Ratio | 5 | 2018 | 448 | 0.220 |
Why?
|
| Retrospective Studies | 11 | 2017 | 3135 | 0.220 |
Why?
|
| Physician's Role | 1 | 2003 | 38 | 0.220 |
Why?
|
| Enteral Nutrition | 1 | 2002 | 30 | 0.220 |
Why?
|
| Time Factors | 5 | 2019 | 2013 | 0.210 |
Why?
|
| Anti-Bacterial Agents | 1 | 2004 | 286 | 0.210 |
Why?
|
| Comorbidity | 5 | 2017 | 548 | 0.210 |
Why?
|
| Prostatic Neoplasms | 2 | 2011 | 443 | 0.200 |
Why?
|
| Prognosis | 4 | 2019 | 1369 | 0.200 |
Why?
|
| Radiography, Abdominal | 1 | 2019 | 16 | 0.170 |
Why?
|
| Holidays | 1 | 2019 | 3 | 0.170 |
Why?
|
| Models, Biological | 2 | 2012 | 373 | 0.170 |
Why?
|
| Body Mass Index | 2 | 2017 | 873 | 0.170 |
Why?
|
| Heart Failure | 3 | 2017 | 576 | 0.170 |
Why?
|
| Eggs | 1 | 2018 | 4 | 0.170 |
Why?
|
| Sex Factors | 3 | 2019 | 633 | 0.170 |
Why?
|
| Meat | 1 | 2018 | 15 | 0.170 |
Why?
|
| Internal Medicine | 1 | 2019 | 45 | 0.170 |
Why?
|
| Organ Size | 1 | 2019 | 196 | 0.170 |
Why?
|
| Survival Analysis | 4 | 2019 | 440 | 0.160 |
Why?
|
| Logistic Models | 5 | 2018 | 729 | 0.160 |
Why?
|
| Age Factors | 3 | 2019 | 1120 | 0.160 |
Why?
|
| Continuity of Patient Care | 1 | 2019 | 64 | 0.160 |
Why?
|
| Glycemic Index | 1 | 2017 | 14 | 0.160 |
Why?
|
| Hip Fractures | 1 | 2017 | 30 | 0.150 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2019 | 156 | 0.150 |
Why?
|
| Feeding Behavior | 1 | 2018 | 159 | 0.150 |
Why?
|
| Pneumonia | 1 | 2017 | 62 | 0.150 |
Why?
|
| Nutritional Status | 1 | 2017 | 68 | 0.150 |
Why?
|
| Nutrition Surveys | 4 | 2005 | 137 | 0.150 |
Why?
|
| Myocardial Infarction | 2 | 2018 | 424 | 0.150 |
Why?
|
| Acute Coronary Syndrome | 1 | 2018 | 177 | 0.140 |
Why?
|
| Diabetes Complications | 1 | 2017 | 171 | 0.140 |
Why?
|
| Diet | 1 | 2018 | 356 | 0.140 |
Why?
|
| Aged, 80 and over | 4 | 2019 | 3758 | 0.140 |
Why?
|
| Risk | 4 | 2015 | 292 | 0.140 |
Why?
|
| Smoking | 4 | 2009 | 440 | 0.140 |
Why?
|
| Sulfonylurea Compounds | 5 | 2015 | 7 | 0.130 |
Why?
|
| Social Class | 1 | 2015 | 78 | 0.130 |
Why?
|
| Coronary Artery Disease | 2 | 2017 | 377 | 0.130 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2013 | 135 | 0.130 |
Why?
|
| Lumbar Vertebrae | 1 | 2015 | 99 | 0.130 |
Why?
|
| Multiple Sclerosis | 1 | 2015 | 43 | 0.120 |
Why?
|
| Hematologic Tests | 1 | 2014 | 11 | 0.120 |
Why?
|
| Blood Chemical Analysis | 1 | 2014 | 21 | 0.120 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 864 | 0.120 |
Why?
|
| Algorithms | 3 | 2018 | 468 | 0.120 |
Why?
|
| Healthcare Disparities | 1 | 2015 | 153 | 0.120 |
Why?
|
| Databases, Factual | 2 | 2012 | 333 | 0.110 |
Why?
|
| Decision Making | 1 | 2015 | 181 | 0.110 |
Why?
|
| Continental Population Groups | 1 | 2014 | 221 | 0.110 |
Why?
|
| Albuminuria | 1 | 2013 | 178 | 0.110 |
Why?
|
| Computational Biology | 1 | 2012 | 86 | 0.100 |
Why?
|
| Stroke | 1 | 2017 | 552 | 0.100 |
Why?
|
| Energy Intake | 2 | 2018 | 120 | 0.100 |
Why?
|
| Medical Informatics | 1 | 2011 | 18 | 0.100 |
Why?
|
| Obesity | 1 | 2017 | 1078 | 0.090 |
Why?
|
| Testicular Neoplasms | 1 | 2009 | 17 | 0.090 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2009 | 11 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 1221 | 0.090 |
Why?
|
| Unemployment | 1 | 2009 | 4 | 0.090 |
Why?
|
| Incidence | 3 | 2013 | 1126 | 0.090 |
Why?
|
| Young Adult | 3 | 2013 | 2423 | 0.090 |
Why?
|
| Efficiency | 1 | 2009 | 16 | 0.090 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2009 | 20 | 0.090 |
Why?
|
| ROC Curve | 3 | 2017 | 149 | 0.090 |
Why?
|
| Employment | 1 | 2009 | 49 | 0.090 |
Why?
|
| Quality Assurance, Health Care | 1 | 2009 | 62 | 0.080 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2009 | 48 | 0.080 |
Why?
|
| Health Surveys | 1 | 2009 | 192 | 0.080 |
Why?
|
| Software | 1 | 2009 | 110 | 0.080 |
Why?
|
| Surgical Wound Infection | 1 | 2009 | 74 | 0.080 |
Why?
|
| Decision Support Techniques | 1 | 2009 | 104 | 0.080 |
Why?
|
| Thiazolidinediones | 3 | 2015 | 47 | 0.080 |
Why?
|
| Length of Stay | 1 | 2009 | 295 | 0.080 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2009 | 85 | 0.080 |
Why?
|
| Coronary Disease | 1 | 2009 | 202 | 0.080 |
Why?
|
| Academic Medical Centers | 2 | 2019 | 150 | 0.080 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2017 | 29 | 0.080 |
Why?
|
| Fibrinogen | 1 | 2007 | 42 | 0.070 |
Why?
|
| Triglycerides | 2 | 2005 | 218 | 0.070 |
Why?
|
| Longitudinal Studies | 2 | 2019 | 725 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2008 | 861 | 0.070 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2008 | 137 | 0.070 |
Why?
|
| Hospitalization | 2 | 2019 | 422 | 0.070 |
Why?
|
| Prevalence | 2 | 2019 | 910 | 0.070 |
Why?
|
| Multivariate Analysis | 3 | 2015 | 638 | 0.070 |
Why?
|
| Treatment Outcome | 3 | 2013 | 3123 | 0.070 |
Why?
|
| Iodide Peroxidase | 1 | 2005 | 1 | 0.070 |
Why?
|
| Meta-Analysis as Topic | 1 | 2005 | 39 | 0.070 |
Why?
|
| Thyroglobulin | 1 | 2005 | 2 | 0.070 |
Why?
|
| Thyroid Function Tests | 1 | 2005 | 4 | 0.070 |
Why?
|
| Thyrotropin | 1 | 2005 | 9 | 0.070 |
Why?
|
| Thyroxine | 1 | 2005 | 16 | 0.070 |
Why?
|
| Emergency Service, Hospital | 2 | 2019 | 440 | 0.070 |
Why?
|
| Epidemiologic Methods | 1 | 2005 | 24 | 0.070 |
Why?
|
| Dietary Fiber | 1 | 2005 | 19 | 0.060 |
Why?
|
| Lipoproteins, LDL | 1 | 2005 | 77 | 0.060 |
Why?
|
| Mental Recall | 1 | 2005 | 52 | 0.060 |
Why?
|
| Confidence Intervals | 1 | 2005 | 141 | 0.060 |
Why?
|
| Oxidation-Reduction | 1 | 2005 | 251 | 0.060 |
Why?
|
| Ferritins | 1 | 2004 | 46 | 0.060 |
Why?
|
| Lipids | 1 | 2005 | 215 | 0.060 |
Why?
|
| Cholesterol, HDL | 1 | 2004 | 167 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2018 | 2041 | 0.060 |
Why?
|
| Chaplaincy Service, Hospital | 1 | 2003 | 1 | 0.060 |
Why?
|
| Nutrition Disorders | 1 | 2002 | 12 | 0.060 |
Why?
|
| Registries | 2 | 2015 | 280 | 0.060 |
Why?
|
| Gastroscopy | 1 | 2002 | 9 | 0.060 |
Why?
|
| Canada | 1 | 2002 | 49 | 0.050 |
Why?
|
| Gastrostomy | 1 | 2002 | 17 | 0.050 |
Why?
|
| Lipoproteins, HDL | 1 | 2005 | 247 | 0.050 |
Why?
|
| Information Dissemination | 1 | 2002 | 42 | 0.050 |
Why?
|
| Quality of Health Care | 1 | 2003 | 135 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2004 | 469 | 0.050 |
Why?
|
| Glipizide | 2 | 2012 | 2 | 0.050 |
Why?
|
| Glyburide | 2 | 2012 | 3 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2005 | 312 | 0.050 |
Why?
|
| African Americans | 1 | 2007 | 1375 | 0.040 |
Why?
|
| Exercise | 1 | 2005 | 608 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 727 | 0.040 |
Why?
|
| Diet Surveys | 1 | 2018 | 56 | 0.040 |
Why?
|
| Troponin | 1 | 2018 | 82 | 0.040 |
Why?
|
| Mass Screening | 1 | 2019 | 226 | 0.040 |
Why?
|
| Accidental Falls | 1 | 2019 | 211 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2017 | 92 | 0.040 |
Why?
|
| Cerebrovascular Disorders | 1 | 2017 | 48 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 2121 | 0.040 |
Why?
|
| Quality of Life | 1 | 2002 | 828 | 0.040 |
Why?
|
| Goals | 1 | 2016 | 36 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2016 | 162 | 0.030 |
Why?
|
| Hyperglycemia | 1 | 2016 | 82 | 0.030 |
Why?
|
| Radiculopathy | 1 | 2015 | 5 | 0.030 |
Why?
|
| Spinal Cord Diseases | 1 | 2015 | 12 | 0.030 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2015 | 3 | 0.030 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2015 | 11 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2015 | 274 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2017 | 469 | 0.030 |
Why?
|
| Insurance Coverage | 1 | 2015 | 74 | 0.030 |
Why?
|
| North Carolina | 1 | 2019 | 1428 | 0.030 |
Why?
|
| Immunologic Factors | 1 | 2015 | 48 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 273 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2018 | 571 | 0.030 |
Why?
|
| Biguanides | 1 | 2013 | 3 | 0.030 |
Why?
|
| Ohio | 1 | 2013 | 55 | 0.030 |
Why?
|
| Benzamides | 1 | 2013 | 54 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 1381 | 0.030 |
Why?
|
| Survival Rate | 1 | 2015 | 796 | 0.030 |
Why?
|
| Propensity Score | 1 | 2012 | 34 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2015 | 423 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 155 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 328 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2012 | 199 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2011 | 85 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 321 | 0.020 |
Why?
|
| Hypertension | 1 | 2017 | 917 | 0.020 |
Why?
|
| Ileostomy | 1 | 2009 | 8 | 0.020 |
Why?
|
| Skilled Nursing Facilities | 1 | 2009 | 9 | 0.020 |
Why?
|
| Proctocolectomy, Restorative | 1 | 2009 | 14 | 0.020 |
Why?
|
| Colectomy | 1 | 2009 | 25 | 0.020 |
Why?
|
| Lymph Node Excision | 1 | 2009 | 89 | 0.020 |
Why?
|
| Disease Progression | 1 | 2011 | 574 | 0.020 |
Why?
|
| Reoperation | 1 | 2009 | 204 | 0.020 |
Why?
|
| Walking | 1 | 2009 | 185 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2009 | 438 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2011 | 337 | 0.020 |
Why?
|
| Coronary Artery Bypass | 1 | 2009 | 100 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2009 | 182 | 0.020 |
Why?
|
| Survivors | 1 | 2009 | 148 | 0.020 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2007 | 15 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2007 | 81 | 0.020 |
Why?
|
| Kidney Transplantation | 1 | 2011 | 353 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 673 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2007 | 486 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2005 | 188 | 0.020 |
Why?
|
| Age Distribution | 1 | 2005 | 199 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 2004 | 34 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 547 | 0.010 |
Why?
|